The data also showed improved surgical incision wound healing in an in vivo porcine model compared to traditional electrosurgery. The company has filed a 510(k) pre-market notification with the FDA to market the system in the US.
The Peak PlasmaBlade is a low-temperature tissue dissection tool that uses pulsed plasma energy to create surgical incisions and control bleeding.
Paul Blumenthal, professor in the department of obstetrics and gynecology at Stanford University School of Medicine, said: “The findings of this comparative preclinical study of tissue cutting and healing are encouraging because they demonstrated that cuts made with the Peak PlasmaBlade produced minimal collateral damage compared with cuts made with currently available electrosurgical instruments. This is important because collateral tissue damage may impede wound healing, obscure histological analysis, and lead to scarring and infection in surgical patients.”